TWEX LIMITED
Company number 10881833 · Monitor this company
This analysis was written by an AI from the company's public filings. It may contain errors or omissions and is not financial or professional advice.
Financial Health Assessment: TWEX LIMITED (Co. No. 10881833)
Before the examination begins — a note on available data. TWEX LIMITED files under the "Total Exemption Full" regime, meaning it is an audit-exempt small company with limited public disclosure obligations. Critically, no balance sheet, profit & loss, or cash flow figures are available in this record. This assessment is therefore akin to a physical examination without blood tests: I can check the pulse, reflexes, and posture (compliance, governance, structure), but cannot directly measure the internal organs (profitability, liquidity, solvency). The grade below is necessarily provisional.
1. Financial Health Score: C (Provisional)
Why not higher? Financial strength is unverifiable from public data, the equity base is wafer-thin, governance now rests on a single director, and the ownership filings contain contradictions. Why not lower? There are no observable symptoms of distress: the company is active, all filings are current, and it has survived over eight years — well past the failure-prone first five. This is a patient in apparently stable condition, but one who hasn't had bloodwork done.
2. Key Vital Signs
| Vital Sign | Reading | Interpretation |
|---|---|---|
| Compliance pulse | Accounts and confirmation statement both current; nothing overdue | Strong and regular — disciplined administration |
| Corporate age | Incorporated July 2017 (~8.5 years) | Good stamina; statistically resilient survivor |
| Scale (body mass) | Audit-exempt small company; £1,000 share capital | Small frame with minimal shock absorption |
| Capitalisation (blood pressure) | £1,000 equity | Low — very thin buffer against trading losses |
| Governance (reflexes) | One director (name shown to subscribers) after name shown to subscribers's resignation (16 Apr 2026) | Key-person dependency — a single point of failure |
| Ownership (circulation) | Two corporate PSCs each claiming >75%, plus an individual at 25–50% | Conflicting readings — like two thermometers disagreeing |
| Trading presence | Active website (twex.uk); IT consultancy (SIC 62020) | Signs of genuine operating activity |
| Premises | Shelton Street, Covent Garden (a widely used registered-office address) | No visible physical footprint — normal for micro-consultancies, but reduces asset visibility |
3. Symptoms Analysis, Diagnosis & Prognosis
Symptoms observed: - No distress markers — no overdue filings, no insolvency proceedings, active status. The patient shows no signs of acute illness. - Opacity — the audit-exempt filing regime means stakeholders cannot verify solvency, profitability, or cash generation from the public record. - PSC inconsistency — two corporate entities (Tag Capital Group Ltd and Tag Investment Bankers Ltd) cannot each literally own more than 75% of the shares, nor can that coexist with name shown to subscribers's 25–50% holding. This suggests a layered holding structure (one entity controlling another), outdated notifications, or filing errors. Any of these warrants clarification. - Recent governance change — a director resignation in April 2026, one day after the latest confirmation statement, suggests an active administrative transition. - Group dependency — control sits with corporate parents, so cash and profits may move within the group; standalone strength is hard to assess.
Diagnosis: A stable, compliant, long-lived small consultancy with chronic fragility typical of its class — thin capitalisation, dependence on one key individual, and an opaque group ownership structure. Condition: stable but under-observed.
Prognosis: Short-term outlook is stable with no visible distress triggers. Medium-term health depends on factors invisible in the public record: client concentration, cash reserves, and whether the parent group supports or drains the company. Key monitoring points are the 2026 accounts (due September 2027), any correction to the PSC register, and further officer changes.
4. Recommendations
For the directors — preventative medicine: 1. Reconcile the PSC register — the overlapping ownership claims should be corrected or clarified; inaccurate filings create compliance risk and deter counterparties. 2. Address key-person risk — appoint a second director or document a continuity plan. 3. Build reserves — retain profits within the business; £1,000 of share capital offers almost no cushion against a lost client or late payment. 4. Maintain rolling cash-flow forecasts — essential for a consultancy where income is lumpy.
For lenders, clients and partners — due diligence before reliance: 1. Request management accounts and the latest filed balance sheet before extending credit; do not rely on the public record alone. 2. Seek clarity on the group structure — understand the role of Tag Capital Group and Tag Investment Bankers, and whether any intra-group arrangements affect TWEX's assets. 3. Use credit agency reports and trade references, and consider milestone-based payments to limit exposure given the thin capital base.